Extensively drug-resistant tuberculosis; (XDR TB)

i

Extensively drug-resistant tuberculosis; (XDR TB)

Public Domain

January 2013
By National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
Series: TB Elimination

Details

Alternative Title:

XDR TB
Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
Description:

Extensively drug resistant TB (XDR TB) is a rare type of multidrug-resistant tuberculosis (MDR TB) that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or capreomycin). MDR TB is caused by an organism that is resistant to at least isoniazid and rifampin, the two most potent TB drugs.
Content Notes:

CS237891A
Subjects:

Tuberculosis, Multidrug-Resistant
Series:

TB Elimination
Document Type:

Text
Genre:

Patient Education Handout ; Fact Sheet
Place as Subject:

United States
Pages in Document:

electronic resource; remote; 3 p. : digital, PDF file (421.42 KB, 3 p.)
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha-512:8b47019fa0fb7b65453c30332b28fbf0f00cad10d44da99719ee51cbb134f19ad18466ef263143c14e999d14501c5398a4e755e287454bec1620b482a233c053
Download URL:

https://stacks.cdc.gov/view/cdc/13222/cdc_13222_DS1.pdf
File Type:

[PDF - 421.42 KB ]

ON THIS PAGE

Details

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.